Guo Y - Search Results

1

Chidamide, a novel histone deacetylase inhibitor, synergistically enhances gemcitabine cytotoxicity in pancreatic cancer cells.

Qiao Z, Ren S, Li W, Wang X, He M, Guo Y, Sun L, He Y, Ge Y, Yu Q. Qiao Z, et al. Among authors: guo y. Biochem Biophys Res Commun. 2013 Apr 26;434(1):95-101. doi: 10.1016/j.bbrc.2013.03.059. Epub 2013 Mar 27. Biochem Biophys Res Commun. 2013. PMID: 23541946

2

Synergistic antitumor interactions between gemcitabine and clofarabine in human pancreatic cancer cell lines.

Guo Y, Xu X, Qi W, Xie C, Wang G, Zhang A, Ge Y. Guo Y, et al. Mol Med Rep. 2012 Mar;5(3):734-8. doi: 10.3892/mmr.2011.738. Epub 2011 Dec 23. Mol Med Rep. 2012. PMID: 22200913

3

Class I and class II histone deacetylases are potential therapeutic targets for treating pancreatic cancer.

Wang G, He J, Zhao J, Yun W, Xie C, Taub JW, Azmi A, Mohammad RM, Dong Y, Kong W, Guo Y, Ge Y. Wang G, et al. Among authors: guo y. PLoS One. 2012;7(12):e52095. doi: 10.1371/journal.pone.0052095. Epub 2012 Dec 14. PLoS One. 2012. PMID: 23251689 Free PMC article.

4

The impact of V30A mutation on transthyretin protein structural stability and cytotoxicity against neuroblastoma cells.

Zhang F, Hu C, Dong Y, Lin MS, Liu J, Jiang X, Ge Y, Guo Y. Zhang F, et al. Among authors: guo y. Arch Biochem Biophys. 2013 Jul 15;535(2):120-7. doi: 10.1016/j.abb.2013.03.005. Epub 2013 Mar 22. Arch Biochem Biophys. 2013. PMID: 23523753

5

Expression and purification of recombinant NRL-Hsp90α and Cdc37-CRL proteins for in vitro Hsp90/Cdc37 inhibitors screening.

He J, Niu X, Hu C, Zhang H, Guo Y, Ge Y, Wang G, Jiang Y. He J, et al. Among authors: guo y. Protein Expr Purif. 2013 Nov;92(1):119-27. doi: 10.1016/j.pep.2013.09.007. Epub 2013 Sep 19. Protein Expr Purif. 2013. PMID: 24056254

6

Effects of ABCB1 polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy.

Meng H, Guo G, Ren J, Zhou H, Ge Y, Guo Y. Meng H, et al. Among authors: guo y, guo g. Epilepsy Behav. 2011 May;21(1):27-30. doi: 10.1016/j.yebeh.2011.02.015. Epub 2011 Apr 13. Epilepsy Behav. 2011. PMID: 21493161

7

Effects of EPHX1, SCN1A and CYP3A4 genetic polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy.

Yun W, Zhang F, Hu C, Luo X, Xue P, Wang J, Ge Y, Meng H, Guo Y. Yun W, et al. Among authors: guo y. Epilepsy Res. 2013 Dec;107(3):231-7. doi: 10.1016/j.eplepsyres.2013.09.011. Epub 2013 Sep 30. Epilepsy Res. 2013. PMID: 24125961

8

CHK1 inhibition sensitizes pancreatic cancer cells to gemcitabine via promoting CDK-dependent DNA damage and ribonucleotide reductase downregulation.

Liang M, Zhao T, Ma L, Guo Y. Liang M, et al. Among authors: guo y. Oncol Rep. 2018 Mar;39(3):1322-1330. doi: 10.3892/or.2017.6168. Epub 2017 Dec 20. Oncol Rep. 2018. PMID: 29286153

9

Responsive delivery of drug cocktail via mesoporous silica nanolamps.

Muhammad F, Guo M, Wang A, Zhao J, Qi W, Guo Y, Zhu G. Muhammad F, et al. Among authors: guo y, guo m. J Colloid Interface Sci. 2014 Nov 15;434:1-8. doi: 10.1016/j.jcis.2014.07.024. Epub 2014 Aug 2. J Colloid Interface Sci. 2014. PMID: 25151090

10

Cucurbitacin B suppresses proliferation of pancreatic cancer cells by ceRNA: Effect of miR-146b-5p and lncRNA-AFAP1-AS1.

Zhou J, Liu M, Chen Y, Xu S, Guo Y, Zhao L. Zhou J, et al. Among authors: guo y. J Cell Physiol. 2019 Apr;234(4):4655-4667. doi: 10.1002/jcp.27264. Epub 2018 Sep 12. J Cell Physiol. 2019. PMID: 30206930

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45,215 results

Search Page

Filters